JS

Johannes-Peter Stasch

BP Bayer Pharma: 4 patents #12 of 229Top 6%
AG Adverio Pharma Gmbh: 1 patents #1 of 14Top 8%
BG Bayer Intellectual Property Gmbh: 1 patents #21 of 89Top 25%
📍 Grottaferrata, IT: #1 of 3 inventorsTop 35%
Overall (2019): #24,324 of 560,194Top 5%
6
Patents 2019

Issued Patents 2019

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
10292970 Heteroaryl-substituted imidazo[1,2-A]pyridines and their use Alexandros Vakalopoulos, Damian Brockschnieder, Frank Wunder, Tobias Marquardt, Lisa DIETZ +1 more 2019-05-21
10265314 SGC stimulators in combination with additional treatment for the therapy of cystic fibrosis Peter Sandner, Michael Hahn, Markus Follmann 2019-04-23
10259776 Branched 3-phenylpropionic acid derivatives and their use Michael Hahn, Thomas Lampe, Karl-Heinz Schlemmer, Frank Wunder, Volkhart Min-Jian Li +4 more 2019-04-16
10214526 Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof Alexandros Vakalopoulos, Damian Brockschnieder, Frank Wunder, Tobias Marquardt, Lisa DIETZ +1 more 2019-02-26
10189856 Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc) Claudia Hirth-Dietrich, Peter Sandner, Andreas Knorr, Georges Von Degenfeld, Michael Hahn +1 more 2019-01-29
10174021 Substituted pyrazolo[1,5-A]pyridines and their use Alexandros Vakalopoulos, Damian Brockschnieder, Frank Wunder, Tobias Marquardt, Lisa DIETZ +1 more 2019-01-08